2025
SJR Q2
JCR Q3 · 2
4 matched articles
SCIE
Journal detail
Tissue Engineering - Part C: Methods
- Publisher
- Mary Ann Liebert Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1937338419373392
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,542
- Quartile Q2
- H-Index 94
- Cites/doc 1,97
- Docs (3y) 164
- Cites (3y) 433
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2
- 5Y JIF 2,9
- JCI 0,44
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Bioengineering Q3
- Biomedical Engineering Q3
- Medicine (miscellaneous) Q2
Areas
- Chemical Engineering
- Engineering
- Medicine
WoS categories
- Cell & Tissue Engineering | Cell Biology | Engineering, Biomedical | Materials Science, Biomaterials
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,542 | 2 | 2,9 | 0,44 | Q3 | 94 |
| 2024 | Q2 | Q3 | 0,621 | 2,6 | 2,6 | 0,49 | Q3 | 92 |
| 2023 | Q2 | Q3 | 0,603 | 2,7 | 3,4 | 0,56 | Q3 | 92 |
| 2022 | Q2 | Q3 | 0,541 | 3 | 3,1 | 0,54 | Q3 | 92 |
| 2021 | Q2 | Q3 | 0,653 | 3,3 | 3,6 | 0,55 | Q3 | 92 |
| 2020 | Q2 | Q3 | 0,846 | 3,1 | 3,5 | 0,61 | Q3 | 92 |
| 2019 | Q2 | Q2 | 0,844 | 2,6 | 2,9 | 0,63 | Q3 | 92 |
| 2018 | — | Q2 | — | 2,6 | 3,2 | 0,71 | Q2 | — |
| 2017 | Q1 | — | 0,956 | — | — | — | — | 92 |
| 2016 | Q1 | — | 1,096 | — | — | — | — | 92 |
| 2015 | Q1 | — | 1,174 | — | — | — | — | 92 |
| 2014 | Q1 | — | 1,474 | — | — | — | — | 92 |
| 2013 | Q1 | — | 1,259 | — | — | — | — | 92 |
| 2012 | Q1 | — | 1,259 | — | — | — | — | 92 |
| 2011 | Q1 | — | 1,096 | — | — | — | — | 92 |
| 2010 | Q1 | — | 0,934 | — | — | — | — | 92 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q4 | Q3 | 172/207 |
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 27/32 |
| 2025 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 94/130 |
| 2025 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q4 | Q3 | 47/58 |
| 2024 | CELL BIOLOGY | SCIE | Q3 | Q3 | 139/204 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 22/32 |
| 2024 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 72/124 |
| 2024 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q4 | 41/55 |
| 2023 | CELL BIOLOGY | SCIE | Q3 | Q3 | 139/205 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 22/31 |
| 2023 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 68/123 |
| 2023 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q4 | Q3 | 41/53 |
| 2022 | CELL BIOLOGY | SCIE | Q3 | Q3 | 133/191 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 22/29 |
| 2022 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 60/96 |
| 2022 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q4 | Q3 | 35/45 |
| 2021 | CELL BIOLOGY | SCIE | Q3 | Q3 | 144/195 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 24/29 |
| 2021 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 60/98 |
| 2021 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q3 | 32/45 |
| 2020 | CELL BIOLOGY | SCIE | Q3 | Q3 | 142/195 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 24/29 |
| 2020 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 48/89 |
| 2020 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q3 | 28/41 |
| 2019 | CELL BIOLOGY | SCIE | Q3 | Q3 | 138/195 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 22/29 |
| 2019 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 38/87 |
| 2019 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q3 | 25/38 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 71/162 |
| 2018 | CELL BIOLOGY | SCIE | Q3 | Q2 | 131/193 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 18/26 |